Platelet rich plasma injections for lateral epicondylitis of the elbow reduce the need for surgical intervention.

Graham Hastie, Mazen Soufi, James Wilson, Bibhas Roy
Author Information
  1. Graham Hastie: Central Manchester University Hospitals NHS Trust, Trafford General Hospital, Moorside Road, Manchester M41 5SL, United Kingdom.
  2. Mazen Soufi: Central Manchester University Hospitals NHS Trust, Trafford General Hospital, Moorside Road, Manchester M41 5SL, United Kingdom.
  3. James Wilson: Central Manchester University Hospitals NHS Trust, Trafford General Hospital, Moorside Road, Manchester M41 5SL, United Kingdom.
  4. Bibhas Roy: Central Manchester University Hospitals NHS Trust, Trafford General Hospital, Moorside Road, Manchester M41 5SL, United Kingdom.

Abstract

OBJECTIVE: We aimed to assess the effectiveness of PRP injections in lateral epicondylitis of the elbow as it was felt after PRP introduction the numbers of patients requiring surgery for had reduced.
METHODS: We conducted a retrospective review of cases from the 1 January 2008 to 31st December 2015. The numbers of patients undergoing surgical release and the numbers of patients requiring PRP injections were recorded each year and the numbers of patients requiring surgery was compared pre and post PRP injection to ascertain if PRP introduction reduced surgical intervention.
RESULTS: Prior to PRP, a yearly mean of 12.75 patients underwent surgery, since PRP this reduced to 4.25 patients, P < 0.001. This leads to an absolute risk reduction of 0.773 and number needed to treat of 1.3. PRP injection successfully reduced symptoms in 56/64 (87.5%) patients in our study.
CONCLUSION: We consider PRP injection, for intractable lateral epicondylitis of the elbow, not only a safe but also very effective tool in reducing symptoms and have shown it has reduced the need for surgical intervention in this difficult cohort of patients.

Keywords

References

  1. Am J Sports Med. 2015 May;43(5):1066-71 [PMID: 25656546]
  2. J Clin Diagn Res. 2015 Jul;9(7):RC05-7 [PMID: 26393174]
  3. J Shoulder Elbow Surg. 2013 May;22(5):647-52 [PMID: 23590887]
  4. Am J Sports Med. 2011 Jun;39(6):1200-8 [PMID: 21422467]
  5. Am J Sports Med. 2008 Jun;36(6):1171-8 [PMID: 18326832]
  6. Pain Res Treat. 2014;2014:191525 [PMID: 24579044]
  7. Br J Sports Med. 2011 Sep;45(12):966-71 [PMID: 21406450]
  8. Am J Sports Med. 2014 Feb;42(2):463-71 [PMID: 23825183]
  9. J Shoulder Elbow Surg. 2014 Feb;23(2):273-8 [PMID: 24332953]
  10. Arthroscopy. 2013 Nov;29(11):1851-62 [PMID: 24060428]
  11. Br J Sports Med. 2014 Jun;48(12):952-6 [PMID: 24563387]
  12. J Shoulder Elbow Surg. 2011 Apr;20(3):434-9 [PMID: 21397792]
  13. Am J Med. 2013 Apr;126(4):357.e1-6 [PMID: 23398951]
  14. J Shoulder Elbow Surg. 2014 Oct;23(10):1527-31 [PMID: 25220200]
  15. Am J Sports Med. 2006 Nov;34(11):1774-8 [PMID: 16735582]
  16. J Hand Microsurg. 2015 Dec;7(2):320-5 [PMID: 26578837]
  17. J Craniofac Surg. 2005 Nov;16(6):1043-54 [PMID: 16327552]
  18. Am J Sports Med. 2013 Mar;41(3):625-35 [PMID: 23328738]
  19. J Orthop Surg (Hong Kong). 2015 Apr;23 (1):6-10 [PMID: 25920634]
  20. J Orthop Surg (Hong Kong). 2015 Apr;23 (1):1-5 [PMID: 25920633]
  21. Biomed Res Int. 2015;2015:439309 [PMID: 26114106]

Word Cloud

Created with Highcharts 10.0.0PRPpatientsreducedelbownumberssurgicalinjectionslateralepicondylitisrequiringsurgeryinjectioninterventionintroduction1symptomsneedPlateletrichplasmaOBJECTIVE:aimedassesseffectivenessfeltMETHODS:conductedretrospectivereviewcasesJanuary200831stDecember2015undergoingreleaserecordedyearcomparedprepostascertainRESULTS:Prioryearlymean1275underwentsince425P < 0001leadsabsoluteriskreduction0773numberneededtreat3successfully56/64875%studyCONCLUSION:considerintractablesafealsoeffectivetoolreducingshowndifficultcohortreduceTennis

Similar Articles

Cited By (10)